[AVet] Ketamine Injection

País: Australia

Idioma: inglés

Fuente: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Ingredientes activos:

KETAMINE (AS THE HYDROCHLORIDE)

Disponible desde:

AVET HEALTH LIMITED

formulario farmacéutico:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Composición:

KETAMINE (AS THE HYDROCHLORIDE) UNGROUPED Active 100.0 mg/ml

Unidades en paquete:

20 mL; 50 mL

clase:

VM - Veterinary Medicine

Área terapéutica:

ANAESTHETICS/ANALGESICS

Resumen del producto:

Poison schedule: 8; Withholding period: MEAT: DO NOT USE less than 28 days befor e slaughter for human consumption. MI LK: Milk collected from treated animals within 7 days (14 milkings) following tr eatment MUST NOT BE USED or processed fo r human consumption or fed to bobby calv es. EXPORT SLAUGHTER INTERVAL (ESI): An ESI has not been established for this product. Note—observing the meat withho lding period may not be sufficient to mi tigate potential risks to export trade. Trade advice should be sought from AVET HEALTH PTY LTD on 1300 28 38 28 before u sing this product.; Host/pest details: BIRDS: [DISSOCIATIVE ANAESTHETIC]; CAMEL: [DISSOCIATIVE ANAESTHETIC]; CAT: [DISSOCIATIVE ANAESTHETIC]; CATTLE: [DISSOCIATIVE ANAESTHETIC]; DEER: [DISSOCIATIVE ANAESTHETIC]; DOG: [DISSOCIATIVE ANAESTHETIC]; GOAT: [DISSOCIATIVE ANAESTHETIC]; HORSE - ADULT: [DISSOCIATIVE ANAESTHETIC]; KANGAROO: [DISSOCIATIVE ANAESTHETIC]; KOALA: [DISSOCIATIVE ANAESTHETIC]; PIG: [DISSOCIATIVE ANAESTHETIC]; REPTILE: [DISSOCIATIVE ANAESTHETIC]; SHEEP: [DISSOCIATIVE ANAESTHETIC]; WOMBAT: [DISSOCIATIVE ANAESTHETIC]; Poison schedule: 8; Withholding period: ; Host/pest details: BIRDS: [ANAESTHETIC - LOCAL/GENERAL]; CAT: [ANAESTHETIC - LOCAL/GENERAL]; ECHIDNA: [ANAESTHETIC - LOCAL/GENERAL]; HORSE: [ANAESTHETIC - LOCAL/GENERAL]; MARSUPIAL: [ANAESTHETIC - LOCAL/GENERAL]; REPTILE: [ANAESTHETIC - LOCAL/GENERAL]; ZOO FELIDAE: [ANAESTHETIC - LOCAL/GENERAL]

Estado de Autorización:

Registered

Fecha de autorización:

2023-07-01

Información para el usuario

Product Name:
APVMA Approval No:
[AVet]
Ketamine Injection
90741/134870
Label Name:
[AVet]
Ketamine Injection
Signal Headings:
CONTROLLED DRUG
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
POSSESSION WITHOUT AUTHORITY ILLEGAL
Constituent
Statements:
100 mg/mL KETAMINE (AS HYDROCHLORIDE)
Claims:
A dissociative anaesthetic, for use singly or in combination with
muscle relaxants or
tranquilisers in horses, cattle, sheep, pigs, dogs, cats, goats,
reptiles, birds, wombats,
koalas, kangaroos, camels and deer.
Net Contents:
20 mL
50 mL
Directions for Use:
Restraints:
DO NOT USE in birds that may be used or processed for human
consumption.
DO NOT USE in birds that are producing or may in the future produce
eggs that may be
used or processed for human consumption.
Contraindications:
This product should not be used in animals with renal insufficiency,
history of epilepsy,
cardiovascular insufficiency, myocardial damage or cardiac arrhythmia.
This product is contraindicated for maintenance of hypovolaemic
animals (particularly
haemorrhaging dogs) as greater myocardial oxygen debt is accumulated
and
cardiovascular parameters may rapidly deteriorate.
This product is contraindicated for use in animals with cerebral
trauma or intracranial
lesions as the anaesthetic action of ketamine relies on functioning
cerebral cortex. RLP APPROVED
This product should not be used for major surgery in animals unless
supplemented by
gaseous or barbiturate anaesthetics or muscle relaxant agents.
Precautions:
Ketamine has been shown to cross the placenta, and depression of
neonates may occur if
Ketamine is used for induction of anaesthesia for caesarean section.
Side Effects:
Adverse effects during recovery can be reduced by the use of
acetylpromazine or xylazine.
Ketamine has been reported to cause seizures in dogs within 24 hours
post-injection.
Ketamine has been reported to cause convulsive seizures in some cats
that receive
ketamine at therapeutic doses.
Ketamine causes the eyes of cats to remain open with dilated pupils.
Protectio